Health
Erythropoietin treatment may increase the risk of hip fractures in individuals with kidney failure – News-Medical.Net
Erythropoietin (EPO) is a medication used to stimulate the production of new red blood cells, which is impaired in individuals with kidney failure. Unfortunately,…
Erythropoietin (EPO) is a medication used to stimulate the production of new red blood cells, which is impaired in individuals with kidney failure. Unfortunately, however, the treatment may increase the risk of hip fractures.
In an analysis published in the Journal of Bone and Mineral Research that examined 1997-2013 records from two large U.S. databases, investigators found that EPO doses administered to patients with kidney failure on hemodialysis fluctuated widely over time, and hip fracture…
-
Noosa News21 hours ago‘Just want to know he’s safe’: Family’s German Shepherd asleep in back of stolen ute
-
Noosa News21 hours agoDriver acquitted of murder over lengthy road-rage chase
-
Noosa News21 hours agoFather in custody after horror crash kills partner and daughter in Doomadgee
-
Business23 hours agoEverything you need to know about the latest ANZ dividend